{"id":"W2760908566","doi":"10.1200/jco.2016.34.15_suppl.tps10587","title":"A phase I study of the EZH2 inhibitor tazemetostat in pediatric subjects with relapsed or refractory INI1-negative tumors or synovial sarcoma.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; SMARCB1; Synovial sarcoma; EZH2; Cancer research; SMARCA4; Epithelioid sarcoma; Internal medicine; Sarcoma; Chromatin remodeling; Oncology; Pathology; Chromatin; Biology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006507951,0.00116148,0.001192253,0.0003324753,0.0003156957,0.0005059863,0.0006511975,0.0007341281,0.002545736],"category_scores_gemma":[0.0003261972,0.0003793737,0.0007313442,0.0003267546,0.0005767665,0.0004475398,0.000264219,0.002145111,0.0006590121],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007857812,"about_ca_system_score_gemma":0.001598054,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001699099,"about_ca_topic_score_gemma":0.004750014,"domain_scores_codex":[0.999804,0.00006987874,0.00001002187,0.00003529845,0.00002352655,0.00005737077],"domain_scores_gemma":[0.9996363,0.00003727873,0.00005469583,0.00003130941,0.00002700417,0.0002134083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3719326,0.1478235,0.04007848,0.001249262,0.001841178,0.001919492,0.001031497,0.00515176,0.2096332,0.001065068,0.009883607,0.2083903],"study_design_scores_gemma":[0.1701581,0.7644655,0.03469212,0.00004664133,0.0005482237,0.001729921,0.0002147674,0.001358434,0.01543939,0.0002563987,0.011063,0.0000275287],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936632,0.001183099,0.0006188711,0.0002880084,0.00006108739,0.001713384,0.0009149959,0.00007866805,0.001478702],"genre_scores_gemma":[0.9889149,0.002051729,0.002131645,0.0005178569,0.00007296837,0.001762309,0.002600351,0.00002301192,0.001925197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002545736,"threshold_uncertainty_score":0.008516371,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06141633266939515,"score_gpt":0.4145799057125616,"score_spread":0.3531635730431664,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}